medi-cal glp 1 coverage BREAKING: Ends for Ozempic, Wegovy, Mounjaro & All GLP-1 Weight-Loss Drugs Jan 1, 2026, Sacramento, CA (Nov 2, 2025), California’s Medi-Cal will stop covering GLP-1 drugs (Ozempic, California's Proposal to Cut GLP-1

Each compound targets distinct neurobiological pathwaysneurotrophism (BDNF), GABAergic modulation, neurotransmitter regulation, or sleep architecture

Further areas of investigation include the potential roles of probiotics in supporting bone health

And when you're ready for more targeted support, Wisp offers options like glutathione injections or glutathione nasal spray that can deliver this powerful antioxidant directly where your body can use it

A larger meta-analysis encompassing over 77,000 participants similarly reported a reduced overall risk of respiratory diseases with GLP-1 receptor agonist treatment, but pulmonary fibrosis was not analysed as a discrete outcome, and no fibrotic endpoints were prospectively assessed [64]

Safety Profile and Possible Side Effects Preclinical studies show BPC-157 was well-tolerated with no serious toxicity in mice, rats, rabbits, and dogs